Background A clear cutoff value of galactomannan (GM) has not been established for
chronic pulmonary aspergillosis (CPA) and is frequently extrapolated from invasive …

Chronic pulmonary aspergillosis (CPA) is a chronic progressive lung disease associated
with a poor prognosis and a 5-year mortality rate of approximately 40–50%. The disease is …

Background The chronic pulmonary aspergillosis network (CPAnet) has recently proposed
definitions for treatment outcomes in CPA. However, these definitions need to be validated …

Chronic pulmonary aspergillosis (CPA) is a challenging respiratory infection caused by the
environmental fungus Aspergillus. CPA has a poor prognosis, with reported 1-year mortality …

We read the interesting article by de Oliveira et al. on the performance of various
investigations for diagnosing chronic pulmonary aspergillosis (CPA). 1 The authors …

We read with interest the study by Oliveira and colleagues recently published in the Journal.
1 The authors retrospectively investigated the diagnostic performance of various laboratory …

We are grateful for the interest in our recently published article on the diagnosis of chronic
pulmonary aspergillosis (CPA). 1 We feel that it is important to discuss the challenges and …